Drug factory · FDA FEI 3007083664

Laurus Labs Limited

Plot No. 18, Jawaharlal Nehru Pharma City, Parawada, Anakapalli, India

India: 1

No problems found at FDA's last inspection, Apr 19, 2024.

No Action Indicated: inspectors found no objectionable conditions.

12 drug inspections on record since 2009: 3 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AtropineMakes the active ingredient and tests it Alcon Laboratories, Inc. 0065-0817

FDA inspection history

EndedResultProgramProblems noted
Apr 19, 2024No problems foundDrug Quality Assurance—
Apr 19, 2024No problems foundDrug Quality Assurance—
Jun 14, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 14, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 18, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 18, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 24, 2015No problems foundDrug Quality Assurance—
Apr 24, 2015No problems foundDrug Quality Assurance—
Nov 27, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 27, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 29, 2009No problems foundDrug Quality Assurance—
Oct 29, 2009No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.